BR112012029887A2 - composição farmacêutica - Google Patents

composição farmacêutica

Info

Publication number
BR112012029887A2
BR112012029887A2 BR112012029887A BR112012029887A BR112012029887A2 BR 112012029887 A2 BR112012029887 A2 BR 112012029887A2 BR 112012029887 A BR112012029887 A BR 112012029887A BR 112012029887 A BR112012029887 A BR 112012029887A BR 112012029887 A2 BR112012029887 A2 BR 112012029887A2
Authority
BR
Brazil
Prior art keywords
pharmaceutical composition
pharmaceutical
composition
Prior art date
Application number
BR112012029887A
Other languages
English (en)
Inventor
Carla Christina Schrier
Henricus Johannes Maria Jagt
Original Assignee
Intervet Int Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intervet Int Bv filed Critical Intervet Int Bv
Publication of BR112012029887A2 publication Critical patent/BR112012029887A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/76—Viruses; Subviral particles; Bacteriophages
    • A61K35/768—Oncolytic viruses not provided for in groups A61K35/761 - A61K35/766
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/76—Viruses; Subviral particles; Bacteriophages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18032—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18071—Demonstrated in vivo effect

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
BR112012029887A 2010-06-10 2011-06-09 composição farmacêutica BR112012029887A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP10165577 2010-06-10
US35436110P 2010-06-14 2010-06-14
PCT/EP2011/059555 WO2011154476A1 (en) 2010-06-10 2011-06-09 Anti-tumor composition

Publications (1)

Publication Number Publication Date
BR112012029887A2 true BR112012029887A2 (pt) 2016-08-16

Family

ID=43033387

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112012029887A BR112012029887A2 (pt) 2010-06-10 2011-06-09 composição farmacêutica

Country Status (8)

Country Link
US (2) US20130084264A1 (pt)
EP (1) EP2579884B1 (pt)
JP (1) JP5603486B2 (pt)
CN (1) CN102917717B (pt)
BR (1) BR112012029887A2 (pt)
CA (1) CA2799076A1 (pt)
ES (1) ES2492691T3 (pt)
WO (1) WO2011154476A1 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112739359A (zh) * 2018-07-13 2021-04-30 西奈山伊坎医学院 Apmv及其用于治疗癌症的用途

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1034104C (zh) * 1993-07-05 1997-02-26 大连医学院 肿瘤疫苗的制备方法
DE69519521T2 (de) * 1994-10-03 2001-06-28 Us Gov Nat Inst Health Zusammensetzung enthaltend ein antigen exprimierendes rekombinantes virus und ein immunstimulierendes molekül exprimierendes rekombinantes virus
MXPA01010393A (es) * 1999-04-15 2004-04-02 Pro Virus Inc Tratamiento de neoplasmas con virus.
WO2001020989A1 (en) * 1999-09-22 2001-03-29 Mayo Foundation For Medical Education And Research Therapeutic methods and compositions using viruses of the recombinant paramyxoviridae family
GB0118532D0 (en) * 2001-07-30 2001-09-19 Isis Innovation Materials and methods relating to improved vaccination strategies
CN1690212A (zh) * 2004-04-23 2005-11-02 中国人民解放军军需大学军事兽医研究所 抗肿瘤重组活载体疫苗
EA013615B1 (ru) 2004-11-12 2010-06-30 Байер Шеринг Фарма Акциенгезельшафт Рекомбинантный онколитический парамиксовирус и его применение
US20090208495A1 (en) * 2008-02-14 2009-08-20 Bayer Schering Pharma Ag Anti-tumor effective paramyxovirus

Also Published As

Publication number Publication date
CN102917717B (zh) 2015-10-07
EP2579884A1 (en) 2013-04-17
EP2579884B1 (en) 2014-06-04
ES2492691T3 (es) 2014-09-10
CA2799076A1 (en) 2011-12-15
JP5603486B2 (ja) 2014-10-08
JP2013528197A (ja) 2013-07-08
US20140212386A1 (en) 2014-07-31
US20130084264A1 (en) 2013-04-04
WO2011154476A1 (en) 2011-12-15
CN102917717A (zh) 2013-02-06

Similar Documents

Publication Publication Date Title
SMT201700008B (it) Composizione farmaceutica
SMT201600350B (it) Composizioni farmaceutiche
DK3246018T3 (da) Farmaceutisk sammensætning
SMT201700095B (is) Composizioni farmaceutiche per inalazione
DK2694038T3 (da) Farmaceutisk sammensætning
DK3097925T3 (da) Farmaceutisk sammensætning
BR112012031667A2 (pt) composição
BR112014003052A2 (pt) composições farmacêuticas
BRPI1004940A2 (pt) composição farmacêutica
DK3284467T3 (da) Nikotinholdige farmaceutiske sammensætninger
BR112013011629A2 (pt) composições
BR112012032683A2 (pt) composição
SMT201400069B (it) Formulazione farmaceutica
EE201300005A (et) Ravimkoostis
BRPI1015939A2 (pt) composição farmacêutica
CO6930367A2 (es) Composiciones farmaceúticas
BRPI1012539A2 (pt) composições farmacêuticas
GT201200303A (es) Formulaciones farmacéuticas
DK2654736T3 (da) Hidtil ukendt farmaceutisk sammensætning
IT1394400B1 (it) Composizioni farmaceutiche
BR112012032980A2 (pt) composição
DK2897594T3 (da) Farmaceutisk sammensætning
DK2815752T3 (da) Oral farmaceutisk sammensætning
CO6801722A2 (es) Composiciones farmacéuticas
BR112013008074A2 (pt) combinações farmacêuticas

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2517 DE 02-04-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.

B350 Update of information on the portal [chapter 15.35 patent gazette]